Jul 29 |
3 High Insider Ownership US Stocks With Up To 52% Revenue Growth
|
Jul 15 |
7 Short-Squeeze Stocks That Could Beat Down the Bears
|
Jul 10 |
Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?
|
Jul 1 |
Verrica Pharmaceuticals Settles Cantharidin-Related Lawsuit With Dormer Labs
|
Jul 1 |
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
|
Jun 28 |
High Insider Ownership Growth Stocks On US Exchange For June 2024
|
Jun 27 |
Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
|
May 30 |
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
|
May 30 |
High Insider Ownership Growth Companies On US Exchange May 2024
|
May 15 |
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
|